BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24045276)

  • 1. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry.
    Weinmann A; Koch S; Niederle IM; Schulze-Bergkamen H; König J; Hoppe-Lotichius M; Hansen T; Pitton MB; Düber C; Otto G; Schuchmann M; Galle PR; Wörns MA
    J Clin Gastroenterol; 2014 Mar; 48(3):279-89. PubMed ID: 24045276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanded use of aggressive therapies improves survival in early and intermediate hepatocellular carcinoma.
    Ho EY; Cozen ML; Shen H; Lerrigo R; Trimble E; Ryan JC; Corvera CU; Monto A;
    HPB (Oxford); 2014 Aug; 16(8):758-67. PubMed ID: 24467780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological, Diagnostic and Therapeutic Aspects of Hepatocellular Carcinoma in Morocco: A Case Series and Review of Literature.
    Zouaki I; Aiterrami A; Samlani Z; Oubaha S; Krati K
    Gulf J Oncolog; 2024 May; 1(45):75-90. PubMed ID: 38774936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma in a large Canadian urban centre: stage at treatment and its potential determinants.
    Khalili K; Menezes R; Yazdi LK; Jang HJ; Kim TK; Sharma S; Feld J; Sherman M
    Can J Gastroenterol Hepatol; 2014 Mar; 28(3):150-4. PubMed ID: 24619637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin does not improve survival in patients with hepatocellular carcinoma.
    Bhat M; Chaiteerakij R; Harmsen WS; Schleck CD; Yang JD; Giama NH; Therneau TM; Gores GJ; Roberts LR
    World J Gastroenterol; 2014 Nov; 20(42):15750-5. PubMed ID: 25400459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A-kinase interacting protein 1 (AKIP1) associates with advanced overall disease condition, tumor properties, and unfavorable prognosis in hepatocellular carcinoma patients.
    Fang T; Lu Q
    J Clin Lab Anal; 2020 Jun; 34(6):e23213. PubMed ID: 32133702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later?
    Brustia R; Bouattour M; Allaire M; Lequoy M; Hollande C; Regnault H; Blaise L; Ganne-Carrié N; Vilgrain V; Larrey E; Lim C; Scatton O; Mouhadi SE; Ozenne V; Paye F; Balladur P; Dohan A; Massault PP; Pol S; Dioguardi Burgio M; Sepulveda A; Cauchy F; Luciani A; Sommacale D; Leroy V; Calderaro J; Roudot-Thoraval F; Nault JC; Amaddeo G;
    Ann Hepatol; 2023; 28(6):101141. PubMed ID: 37468096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Merits and boundaries of the BCLC staging and treatment algorithm: Learning from the past to improve the future with a novel proposal.
    Trevisani F; Vitale A; Kudo M; Kulik L; Park JW; Pinato DJ; Cillo U
    J Hepatol; 2024 Apr; 80(4):661-669. PubMed ID: 38266658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic delays are common among patients with hepatocellular carcinoma.
    Patel N; Yopp AC; Singal AG
    J Natl Compr Canc Netw; 2015 May; 13(5):543-9. PubMed ID: 25964640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A global view of hepatocellular carcinoma: trends, risk, prevention and management.
    Yang JD; Hainaut P; Gores GJ; Amadou A; Plymoth A; Roberts LR
    Nat Rev Gastroenterol Hepatol; 2019 Oct; 16(10):589-604. PubMed ID: 31439937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology, therapy and outcome of hepatocellular carcinoma between 2010 and 2019 in Piedmont, Italy.
    Bracco C; Gallarate M; Badinella Martini M; Magnino C; D'Agnano S; Canta R; Racca G; Melchio R; Serraino C; Polla Mattiot V; Gollè G; Fenoglio L
    World J Gastrointest Oncol; 2024 Mar; 16(3):761-772. PubMed ID: 38577451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical guideline SEOM: hepatocellular carcinoma.
    Sastre J; Díaz-Beveridge R; García-Foncillas J; Guardeño R; López C; Pazo R; Rodriguez-Salas N; Salgado M; Salud A; Feliu J
    Clin Transl Oncol; 2015 Dec; 17(12):988-95. PubMed ID: 26607931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routes to diagnosis for hepatocellular carcinoma patients: predictors and associations with treatment and mortality.
    Burton A; Wilburn J; Driver RJ; Wallace D; McPhail S; Cross TJS; Rowe IA; Marshall A
    Br J Cancer; 2024 Jun; 130(10):1697-1708. PubMed ID: 38499728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of disease stage and aetiology on survival in hepatocellular carcinoma: implications for surveillance.
    Johnson P; Berhane S; Kagebayashi C; Satomura S; Teng M; Fox R; Yeo W; Mo F; Lai P; Chan SL; Tada T; Toyoda H; Kumada T
    Br J Cancer; 2017 Feb; 116(4):441-447. PubMed ID: 28081537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening process failures for hepatocellular carcinoma.
    Singal AG; Marrero JA; Yopp A
    J Natl Compr Canc Netw; 2014 Mar; 12(3):375-82. PubMed ID: 24616543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma-the role of the underlying liver disease in clinical practice.
    de Mattos AZ; Bombassaro IZ; Vogel A; Debes JD
    World J Gastroenterol; 2024 May; 30(19):2488-2495. PubMed ID: 38817660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Productivity loss by cancer stage in patients newly diagnosed with hepatocellular carcinoma: A claims database analysis.
    Cheng SJ; Bansal A; Veenstra DL
    J Manag Care Spec Pharm; 2024 Jun; 30(6):572-580. PubMed ID: 38824631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and outcomes of hepatocellular carcinoma in patients with Sickle cell disease: a population-based study in the U.S.
    Barbetta A; Goldbeck C; Lim A; Martin SP; Kahn JA; Sheikh MR; Emamaullee J
    HPB (Oxford); 2022 Feb; 24(2):234-243. PubMed ID: 34294525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the COVID-19 pandemic on patients with hepatocellular carcinoma in the West of Scotland: a cohort study.
    McLaren AS; Spoor JA; Cartwright D; Naylor G; Barclay S; Priest M; Puttagunta S; Armstrong K; Ballantyne S; Stanley A; Jeffry Evans TR;
    BMJ Open Gastroenterol; 2023 Nov; 10(1):. PubMed ID: 37989352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of jaundice in advanced hepatocellular carcinoma - a sub-Saharan perspective.
    Keshaw PB; Bernon M; Emmamally M; Khan R; Segobin R; Creamer D; Krige JEJ; Jonas E; Sobnach S
    S Afr J Surg; 2024 May; 62(2):18-22. PubMed ID: 38838114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.